Provexis (PXS)

 

PXS Share PerformanceMore

52 week high0.5150 18/08/16
52 week low0.2300 09/06/16
52 week change -0.0400 (-8.60%)
4 week volume61,468,616 30/08/16

Latest NewsMore

Director/PDMR Shareholding

RNS Number: 9965J Provexis PLC 15 September 2016 15 September 2016 Provexis plc Directors' Share Purchase Further to its announcements on 9 June 2016, 29 June 2016 and 2 August 2016 and its preliminary results announcement on 7 September 2016, Provexis plc ('Provexis' or the 'Company'), announces that it has raised 25,000 via a placing (the 'Placing'), conditional ...

Provexis reduces FY pretax loss

Provexis has issued its audited preliminary results for the year ended 31 March 2016. HIGHLIGHTS: - Revenue from profit ...

Preliminary Results

RNS Number: 1654J Provexis PLC 07 September 2016 7 September 2016 Provexis plc ("Provexis" or the "Company") PRELIMINARY RESULTS for the YEAR ended 31 MARCH 2016 Provexis plc ("Provexis" or the "Company"), the business that develops and licenses the proprietary, scientifically-proven Fruitflow heart-health functional food ingredient, announces its...

Holding(s) in Company

RNS Number: 8192I Provexis PLC 02 September 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Provexis plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights x An acquisition or dis...

Provexis raises £224,000 at 0.24p/share

Provexis has raised a gross 224,000 via a placing of 93.3m new shares at a discounted 0.24p a share.

Results of Placing

RNS Number: 9171F Provexis PLC 02 August 2016 2 August 2016 Provexis plc Results of placing Provexis plc ("Provexis" or the "Company"), the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow heart-health functional food ingredient, is pleased to announce it has raised a gross 224,000 via a placing (the "Placing"), conditional on a...

Study Publication

RNS Number: 8709D Provexis PLC 12 July 2016 12 July 2016 Provexis plc Study publication - Fruitflow: the first European Food Safety Authority-approved natural cardio-protective functional ingredient Provexis plc (" Provexis " or the " Company "), the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow heart-health functional fo...

Funding Update

RNS Number: 5689C Provexis PLC 29 June 2016 29 June 2016 Provexis plc Funding Update Provexis plc ("Provexis" or the "Company"), the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow heart-health functional food ingredient, provides an update to its announcement on 9 June 2016 concerning funding. The Company's announ...

Fundamental DataMore

EPS-0.03
Dividend yield0 %

Latest discussion posts More

  • Duttaroy Snippet

    "My new book ?Nutraceuticals and Human blood platelet function: Application in Cardiovascular Health? will be published by Wiley in 2017 The book will describe the current ...
    25-Sep-2016
    gixer
  • World Heart Day

    Our round table event is not the only thing happening on the 29th. http://www.world-heart-federation.org/what-we-do/world-heart-day/
    25-Sep-2016
    gixer
  • Re: Big week next week

    It needs to be as the highs and lows are getting lower.
    23-Sep-2016
    nest of rampers

Users' HoldingsMore

Users who hold Provexis also hold..
SCIENCE SPRT59%
GULF KEYSTONE18%
ID:ISIN:BMG4209G124418%
ID:ISIN:BMG4209G132718%
LLOYDS GRP.15%

Codes & Symbols

ISINGB00B0923P27
SymbolsPXS, LSE:PXS, PXS.L, PXS:LN, LON:PXS, XLON:PXS